Location: The Francis Crick Institute, Midland Road, London
The Systems Chemical Biology of Infection and Resistance Lab studies how pathogenic bacteria survive and infect, using chemical biology and genetic tools to define new gene targets and their chemical inhibitors. Ultimately, we aim to enable antimicrobial therapies which exploit key weaknesses in the ability of pathogenic bacteria to evolve resistance to antibiotics. Working at the interface of genetics, chemical biology, and machine learning, we discover and use small molecules to precisely disrupt the cellular machinery of pathogenic bacteria and study consequent effects on survival, infection, and evolution.
The project focuses on the intersection of systems biology and chemical biology approaches to the problem of antimicrobial resistance in tuberculosis. As soon as new antimicrobial drugs are discovered and used in the clinic, pathogenic bacteria inevitably evolve resistance, driving an unsustainable cycle threatening the twentieth century’s improvements to public health. Antibiotics revolutionized modern medicine, but once again millions of lives are threatened by pathogenic bacteria like M. tuberculosis.
In this project, some of the specific aims could include but not be limited to:
The postholder will be responsible for:
The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.
An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London.
The Crick was formed in 2015, and in 2016 it moved into a new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under in one building in Europe.
The Francis Crick Institute will be world-class with a strong national role. Its distinctive vision for excellence includes commitments to collaboration; developing emerging talent and exporting it the rest of the UK; public engagement; and helping turn discoveries into treatments as quickly as possible to improve lives and strengthen the economy.